Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1998-02-04
2000-08-22
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242241, 4242321, A61K 3912, A61K 39275, A61K 39205
Patent
active
061068411
ABSTRACT:
The present invention relates to a novel method to immunize an animal against a heterologous antigen. The method includes the step of administering to the animal, by an intranasal route, a conjunctival route, or a combination thereof, a composition comprising a recombinant raccoon poxvirus having a nucleic acid molecule encoding such a heterologous antigen. Animals to be immunized include those that are susceptible to such routes of recombinant raccoon poxvirus administration. Preferred animals to immunize include felids. Preferably, any immune response generated by the animal against viral antigens of the recombinant raccoon poxvirus is sufficiently small so as to not prevent the animal from eliciting an immune response to a heterologous antigen encoded by a recombinant raccoon poxvirus subsequently administered to the animal.
REFERENCES:
patent: 5266313 (1993-11-01), Esposito et al.
patent: 5348741 (1994-09-01), Esposito et al.
patent: 5607846 (1997-03-01), Murphy et al.
patent: 5656275 (1997-08-01), Wasmoen et al.
Hu et al. "raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine". Vaccine. vol. 15, No. 12/13, pp. 1466-1472, 1997.
Hu et al. "raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge". Virology. vol. 218, 248-252, 1996.
Ramshaw et al. "expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo". Immunological Reviews. vol. 127, pp. 157-182, 1992.
Esposito et al, Advances in Veterinary Science and Comparative Medicine 33:195-247, 1989.
Hall et al, The Lancet, Jan. 10, 1987, p. 111.
O'Connor et al, British Journal of Opthamology 74:245-246, 1990.
Ngichare, Dissertation Abstracts International 53 (8):3936-B, 1993.
Esposito et al., 1988, Virology 165, pp. 313-316.
Esposito et al., 1992, Vaccines 92, pp. 321-329.
Herman, 1964, Bacteriol. Proc. 64th Annual Meeting of the Am. Soc. Microbiol., p. 117.
Thomas et al., 1975, Archives of Virology 49, pp. 217-227.
Lutze-Wallace et al., 1995, Virus Genes 10:1, pp. 81-84.
Scott, F. W., 1988, 69th Conf. Res. Workers Anim. Dis., Abstract 60.
Database WPI, Week 9711, Derwent Publications, Ltd., XP002107225, Jan. 7, 1997.
Database WPI, Week 9135, Derwent Publications, Ltd., XP002107226, Jul. 23, 1991.
DeMartini et al., 1993, Arch Virol, 133, pp. 211-222.
Osorio Jorge E.
Stinchcomb Dan T.
Heska Corporation
Mosher Mary E.
LandOfFree
Delivery method for recombinant raccoon poxvirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delivery method for recombinant raccoon poxvirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery method for recombinant raccoon poxvirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577610